Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Etanercept (GP2015) and Enbrel (EGALITY)
Read time: 1 mins
Last updated:24th Jun 2013
The purpose of this study is to demonstrate equivalent efficacy of GP2015 and Enbrel� in patients with moderate to severe chronic plaque-type psoriasis with respect to PASI 75 response rate at Week 12.
|Study start date||2013-06-24|